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Pluripotency in human embryonic stem cells (hESCs) and induced pluripotent stem
cells (iPSCs) is regulated by three transcription factors—OCT3/4, SOX2, and NANOG.
To fully exploit the therapeutic potential of these cells it is essential to have a good
mechanistic understanding of the maintenance of self-renewal and pluripotency. In this
study, we demonstrate a powerful systems biology approach in which we first expand
literature-based network encompassing the core regulators of pluripotency by assessing
the behavior of genes targeted by perturbation experiments. We focused our attention
on highly regulated genes encoding cell surface and secreted proteins as these can be
more easily manipulated by the use of inhibitors or recombinant proteins. Qualitative
modeling based on combining boolean networks and in silico perturbation experiments
were employed to identify novel pluripotency-regulating genes. We validated Interleukin-11
(IL-11) and demonstrate that this cytokine is a novel pluripotency-associated factor capable
of supporting self-renewal in the absence of exogenously added bFGF in culture. To
date, the various protocols for hESCs maintenance require supplementation with bFGF
to activate the Activin/Nodal branch of the TGFβ signaling pathway. Additional evidence
supporting our findings is that IL-11 belongs to the same protein family as LIF, which is
known to be necessary for maintaining pluripotency in mouse but not in human ESCs.
These cytokines operate through the same gp130 receptor which interacts with Janus
kinases. Our finding might explain why mESCs are in a more naïve cell state compared
to hESCs and how to convert primed hESCs back to the naïve state. Taken together, our
integrative modeling approach has identified novel genes as putative candidates to be
incorporated into the expansion of the current gene regulatory network responsible for
inducing and maintaining pluripotency.
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1. INTRODUCTION
With the ever-growing number of experimental datasets avail-
able, the question of how to reuse data smartly to gain knowl-
edge and advance fundamental understanding of the regulatory
nature of biological systems computational methods become
ever more essential. Computational methods provide a way to
unravel hidden relationships and regulations between genes that
would otherwise be tedious and hard to achieve with traditional
approaches. Modeling and simulations should be considered as a
complementary approach to the in-depth gene function analysis.
Several research fields are advancing fast thanks to the improve-
ment in technologies. Human embryonic stem cells (hESC) and
induced pluripotent stem cells (iPSC) are creating major hope
and research activities. These cell types are thought to be cru-
cial to pave the way for regenerative therapies, because they are
pluripotent as defined by the ability to self-renew while retaining
the capacity to differentiate into all lineages of the embryo proper.
This ensures both, a constant supply of cells in vitro and, at least
equally important, the generation of donor cells for therapy. A
prerequisite, however, is to understand the pluripotent state and
how the undifferentiated state is maintained, as a single undif-
ferentiated pluripotent stem cell that escapes the differentiation
induction could give rise to for example tumor due to its intrinsic
self-renewing characteristics. For future cell replacement ther-
apies, it is of prime importance to be able to generate iPSCs
efficiently and robustly with well defined culture conditions.
The gene regulatory network supportive of self-renewal is
orchestrated by three transcription factors, namely OCT3/4,
SOX2, and NANOG (Boyer et al., 2005). Pluripotency is induced
in somatic cells by the over-expression of distinct combinations of
these transcription factors—OCT3/4, SOX2, KLF4, and c-MYC
(Takahashi and Yamanaka, 2006) or OCT3/4, SOX2, NANOG,
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and LIN28 (Yu et al., 2007). Although other genes are known to
be associated with the main regulators as well, the overall regula-
tory network representing the pluripotent embryonic stem cell is
still lacking completeness and potentially other regulatorymecha-
nisms that would be able to describe both stem-cell like properties
and the differentiation paths that the cells could undergo.
As mentioned above, only a small number of highly reliable
transcription factors and signaling pathways active in hESCs are
known (Armstrong et al., 2006; Vallier et al., 2009; Brown et al.,
2011; Singh et al., 2012). Therefore, there is a need to expand
and identify novel regulators, including secreted components that
could be added to the culture media to sustain self renewal. Using
a large set of experimental data (in our case mRNA expression
data) together with in silico modeling methods we attempted to
identify factors responsible for self renewal in human embryonic
stem cells.
Previously, regulatory networks of hESCs were mostly con-
structed using transcription factor binding experiments or pro-
tein interaction data (Boyer et al., 2005; Wang et al., 2006; Kim
et al., 2008;Muller et al., 2008). Recent developments of collecting
human and mouse embryonic stem cell related experimental data
sets into specialized databases like ESCDb (Jung et al., 2010) and
ESCAPE (Xu et al., 2013) facilitate data reuse and combining in
systematic studies of ESC regulation. Lately, Flöttmann and col-
leagues have shown the power of combining various experimental
data sources with network modeling to gain new insights into cel-
lular reprogramming (Flottmann et al., 2012). Boolean modeling
has also been recently used by Bonzanni and colleagues to pro-
pose and validate a new regulatory connection of Gata1 regulating
Fli1 in hematopoietic stem cells triggering erythrocyte lineage dif-
ferentiaton (Bonzanni et al., 2013). For kinetic data and smaller
network sizes stochastic modeling might be used as Kalmar and
others did show how NANOG expression fluctuations mediate
cell fate decisions in embryonic stem cells (Kalmar et al., 2009).
Regulatory networks are likely to be rich in different types
of feedback and feedforward loops that carry the complexity of
the network and provide the needed robustness of regulation
(Milo et al., 2002; Remy et al., 2006; Macarthur et al., 2009).
Gene regulatory networks are complex and act in more activa-
tion layers than only transcription factor and target gene level.
Embryonic stem cell specific regulation can also be controlled by
alternative splicing mediated regulatory switch. Gabut and others
showed that FOXP1 transcription factor DNA binding domain is
altered by alternative splicing of exon 18b in ESCs and that iso-
form targets core pluripotency regulators in hESCs (Gabut et al.,
2011). Recently, Wang and colleagues identified a feedback loop
active in at least two regulatory levels in hESCs. They showed
that large intergenic non-coding RNA (linc-RoR) together with
miR-145 and core hESC pluripotency transcription factors forms
a double negative feedback loop active in ESC self-renewal (Wang
et al., 2013). The identification of regulatory feedback loops are
experimentally challenging and it is important to come up with
strategies that can identify candidate genes and regulatory edges
to expand any given cellular decision network.
In this study we use an in silico approach to identify novel
potential regulators of undifferentiated human embryonic stem
cell regulatory networks by using gene perturbation experiments
together with qualitative modeling (Garg et al., 2009). Qualitative
modeling suits best for large networks where edges represent both
direct and indirect regulation, such as extracted from pertur-
bation datasets, and kinetic data for all network components is
difficult and even impossible to obtain. As a first step, we present
a methodology for predicting new candidate genes from a given
regulatory network structure. In order to identify candidate genes
we set a four step approach: (i) we create a first regulatory network
of the 10 core genes (e.g., OCT3/4, SOX2, NANOG); (ii) we iden-
tify the set of genes that were perturbed by several transcription
factors and are either surface markers or secreted proteins (such
as cytokines) (we retained 109 genes regulated by at least 5 out of
7 regulators); (iii) we connected these set of genes to core regu-
latory network (exploring all possible connections of inhibition
and activation); (iv) we simulated in silico knockout and over-
expressed each of the node and assessed through a scoring func-
tion whether the predicted network maintained pluripotency or
induced differentiation. Our computational perturbation exper-
iments revealed a new set of putative pluripotency regulating
genes. We further show that one of these candidate genes, IL-11,
supports the undifferentiated state of hESCs. Moreover, IL-11 is
capable of substituting bFGF in the culture media. To date bFGF
is considered irreplaceable in the culture media for maintaining
hESCs in pluripotent state.
The activity of pathways in terms of signal transduction that
maintain the undifferentiated state upstream of OCT3/4, SOX2,
and NANOG or independent of this triad is at least partly mir-
rored in the composition of the culture media. Traditionally,
hESCs are co-cultured with inactivated mouse embryonic fibrob-
lasts (MEFs) supplemented with bFGF (FGF2) at a concen-
tration of 4 ng/ml (Thomson et al., 1998), until Xu and col-
leagues established hESC culture on matrigel in the presence
of MEF-conditioned medium (CM). However, it also needs the
supplementation with bFGF (Xu et al., 2001). Later Bigdeli
and others managed to culture hESCs in matrix and feeder-
free culture conditions using neonatal chondrocyte-conditioned
medium (Bigdeli et al., 2008). Others reported that bFGF sustains
undifferentiated proliferation of hESC by simultaneous suppres-
sion of BMP4 whereby the culture conditions can be supported by
adding NOGGIN as a BMP inhibitor (Xu et al., 2005b). Later, this
group developed a feeder-free and matrigel-free TeSR1 medium,
containing DMEM/F12 as base medium, human serum albumin,
bFGF, TGFβ1, LiCl, GABA, pipecolic acid on a combination of
collagen IV, fibronectin, laminin and vitronectin including high
amounts of bFGF (100 ng/ml instead of 4 ng/ml) (Ludwig et al.,
2006).
In 2010 it was reported that a chimeric version of IL-6 fused to
its receptor when added to hESCs and allowed their cultivation in
suspension. However, this was only possible with the simultane-
ous application of bFGF (Amit et al., 2010). Recently, the group
of James Thomson re-formulated the TeSR1 medium composed
of a simpler formulation (Chen et al., 2011). This medium, which
they have named E8, is based on 8 elements, instead of 18 as in
TeSR1. They started component pairwise analysis and found that
the withdrawal of BSA is no longer toxic when removed together
with β-Mercaptoethanol. It turned out that upon removal of BSA
and β-Mercaptoethanol, the ingredients pipecolic acid, GABA,
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LiCl, chemically defined lipids, trace elements B and C, glu-
tathione, additional thiamine and L-glutamine no longer had
positive effects. The remaining 8 factors in the E8 medium are
FGF2, TGFβ, NODAL, Insulin, Selenium, Transferrin, L-Ascorbic
Acid, and DMEM-F12 (Chen et al., 2011). Like this report, many
research articles have been published varying slightly or intro-
ducing major variations to culture conditions. However, most
protocols center around the presence of bFGF in the chemically
defined media or in conditioned medium (Rosler et al., 2004; Li
et al., 2005; Wang et al., 2005, 2007; Xu et al., 2005a,b; Levenstein
et al., 2006; Ludwig et al., 2006; Greber et al., 2007a). bFGFs ben-
efitial effect is due to its signaling through MEK/ERK pathway
(Kang et al., 2005).
The mechanism employed by bFGF acts besides on the hESCs
themselves also on the mouse embryonic feeder cells or when cul-
tured on matrigel on hESC-derived fibroblast like support cells
(autologous feeders). The feeder cells produce and release sup-
portive factors for the maintenance of undifferentiated hESCs
(Bendall et al., 2007; Greber et al., 2007a). Some of these factors
are TGFB1, INHBA, IGFII activating MEK/ERK, and PI3K/AKT
signaling and the BMP4 antagonists CER1 and GREM1 which
collectively inhibit induction of differentiation via SMAD1/5/8.
Further downstream targets of bFGF are transcription factors
involved in proliferation such as c-FOS, MYC, and ETS2 (Greber
et al., 2007a). Like the bFGF pathway, the inhibition of TGFβ
which acts via SMAD2/3 signaling induces differentiation of both
hESCs and iPSCs (Greber et al., 2008).
2. RESULTS
2.1. PLURIPOTENCY NETWORK MODEL BASED ON GENE
PERTURBATION EXPERIMENTS
The literature based regulatory network of hESCs is largely built
on knowledge from (Xu et al., 2002; Matin et al., 2004; Boyer
et al., 2005; James et al., 2005; Vallier et al., 2005; Babaie et al.,
2007; Greber et al., 2007a; Kim et al., 2008; Xu et al., 2008; Chavez
et al., 2009; Lister et al., 2009; Jung et al., 2010) on the regulation
and interplay between several transcription factors (Figure 2A).
First, we expanded initial literature-based regulatory network of
hESC using a set of seven perturbation experiments including—
NANOG, SOX2, and OCT3/4 RNAi knockdowns in human
embryonal carcinoma cells (NCCIT) (Greber et al., 2007b); bFGF,
BMP4 and ACTA protein stimulation in H1 embryonic stem cells
(Greber et al., 2008); GADD45G over-expression in NCCIT cells
(Jung et al., 2010) from our previously published Embryonic Stem
Cell Database (ESCDb, Figure 2B) (Jung et al., 2010). Human
embryonal carcinoma cells (hECCs) are the malignant counter-
part of hESCs and are frequently used as a model system for
hESCs, in particular in terms of RNAi experiments. Although
more limited, most likely due to their malignant character, they
do have the capacity to differentiation into several cell types, and
like hESCs, they undergo symmetric self-renewal (Andrews et al.,
1987; Matin et al., 2004; Bahrami et al., 2005; Josephson et al.,
2007). In fact, their capacity to self-renew is governed by almost
the same gene circuitries for example, OCT3/4, SOX2, NANOG,
DNMT3B, DPPA2, DPPA3, DPPA4, and GABRB3 (Enver et al.,
2005; Greber et al., 2007b). Given that hESCs are genetically far
more difficult to manipulate and even if successful, the efficiency
is dissapointingly low, hECCs are frequently employed for this
purpose and in comparison with genetic manipulations in hESCs
they do provide useful and complementary results.
In the above mentioned seven perturbation experiments we
identified differentially expressed genes (above and below thresh-
old of 1.5 fold change on log2 scale) and filtered the genes
based on their response to over-expression and knockdown of
the selected genes (e.g., NANOG) in embryonal carcinoma and
embryonic stem cells. These 7862 genes whose responses were sig-
nificantly modified (either up or down-regulated) at a p-value of
1.0e-05 or smaller were then connected to the regulatory network
in either a positive or a negative regulation (see full workflow in
Figure 1). Since the expression of thousands of genes is affected by
the many regulators’ perturbation experiments, we concentrated
on 488 genes that are affected by at least 5 perturbations, assum-
ing that these genes are under coordinated or potentially synergis-
tic control. We filtered genes by their Gene Ontology functional
annotations and selected genes related to receptor related signal-
ing pathways mainly because they are easier to interfere with at
the protein level using either inhibitors or recombinant proteins.
The 109 genes in this resulting network can be grouped together
by their incoming edges, thus forming 59 clusters of genes that
are under similar regulation and therefore can be grouped as one
node in the final network, enabling faster computation. By group-
ing genes by their incoming edges we investigate the potential role
of a novel feedback loop, connecting genes under a specific regu-
lation to a regulator, in maintaining the pluripotency. Individual
genes in a cluster might behave differently if studied in more
FIGURE 1 | Modeling pipeline described by individual steps for an
overview of the full workflow.
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FIGURE 2 | Initial literature-based network (A) was expanded using 7
perturbation experiments from ESCDb (B). This resulted in a big
hairball like network that was reduced by keeping only genes belonging
to receptor binding GO categories (GO:0007166, GO:0005102) and
having at least 5 incoming edges. All genes that had identical set of
incoming edges were clustered together (C) with all their edges
described in the panel below (D). Finally, new regulatory edges were
introduced creating feedback loops from clusters to regulators (dashed
red line edge from C36 to ACTA) thus producing individual regulatory
models (E).
detail. However, the majority of clusters contain only one or two
genes and the effect of the individual genes will be evaluated sepa-
rately for each gene in the experimental step. Using these steps we
obtained a network composed of 69 nodes where 10 are from the
core network and the rest are clusters of genes that are regulated
by at least 5 out of the 7 main regulators (Figure 2C).
In the evaluation procedure we assessed the role of a regulatory
edge from a terminal node (cluster of genes) to any of the core reg-
ulators (part of the core network), thus creating a new feedback
loop to the network (Figure 2E). We produced two models—one
with a positive and one with a negative regulation for each of the
clustered genes (named CX, where X represents the cluster num-
ber, e.g., C13). In total we created a set of 1180 models where each
of the introduced edges connected the 59 terminal nodes to 10
core regulators as potential targets in both positive and negative
manner (59∗10∗2). Each model was then submitted to the bool-
Sim (Garg et al., 2009) logical modeling simulations. boolSim
produced a set of steady states for each model. We subsequently
performed in silico knock-out and over-expression to each of the
regulatory nodes contained within the models and thus obtained
an ensemble of steady states that represent the effect of introduced
feedback loop to pluripotency maintenance.
We applied a PCA transformation to thematrix of steady states
and identified the contributions of two classes of genes that we
consider either maintaining pluripotency or inducing differenti-
ation. Namely, we used OCT3/4, SOX2 and NANOG as pluripo-
tency marker genes and GADD45G and BMP4 as differentiation
markers and used their respective eigenvectors. For each model
we calculated angles between the five eigenvectors in the follow-
ingmanner—we calculated an average angle from the three angles
between SOX2 and NANOG, SOX2, and OCT3/4, and NANOG
and OCT3/4; secondly, we calculated an angle between BMP4
and GADD45G; finally, we calculated the angle between the first
group (NANOG, SOX2, OCT3/4) representing pluripotency and
second group (BMP4, GADD45G) representing differentiation
process. Models that produced small angles between pluripotency
markers and at the same time a large angle between pluripotency
and differentiationmarkers were selected as depicted in Figure 3A
(selected markers marked in red). We selected the set of mod-
els that fulfills criteria of maintaining pluripotency and blocking
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FIGURE 3 | Model scoring. (A) Each model was scored using sum of angles
between pluripotency markers (x-axis) and an angle between pluripotency
and differentiation markers (y -axis). Models selected for validation (marked
with red) had small angles between pluripotency markers and large angle
between pluripotency and differentiation markers. Expression of each
predicted factor was measured in embryoid body (B) and OCT3/4 (C)
mediated differentiation. Asterisk marks significant values with
p-values < 0.05.
differentiation. Using this approach we identified and selected the
top 8 clusters corresponding to 15 cytokines, cytokine receptors
or cytokine pathway associated factors which previously were not
associated with the undifferentiated state and now appeared as
candidates that might support pluripotency. We set our goal at
8 clusters mainly for feasibility reasons, but it is likely that other
models might hold interesting genes that are amenable for further
validation.
2.2. MODELING PIPELINE IDENTIFIED 15 NOVEL CYTOKINE PATHWAY
ASSOCIATED FACTORS
These 15 novel cytokines, cytokine receptors or cytokine pathway
associated factors that were predicted to support the undifferenti-
ated state by qualitative modeling are ADRA2C, EPHB2, EPHB3,
CD99, CXCL12, CXCR7, FRAT2, FUT8, IL-11, JUN, MAP7D1,
NEDD9, NRIP1, PLXNA2, WNT3 (Table 1). Most of these fac-
tors have so far not been associated with the pluripotent state
before. As a first step in validating our results, we checked the
expression patterns of the predicted factors in studies previously
reported by us (Greber et al., 2007b; Fathi et al., 2009). Indeed,
we could confirm the predicted pluripotency associated factors to
be differentially expressed upon embryoid body (EB)-based dif-
ferentiation and, in a second data set, upon OCT3/4 depletion in
hESC line H1 (Figures 3B,C). In these datasets the predicted fac-
tors can be divided into two categories. The first set is composed
of genes that are down-regulated upon differentiation CD99,
CXCR7, EPHB2, EPHB3, FUT8, IL-11, MAP7D1, NEDD9, NRIP1,
PLXNA2, WNT3 prompting the question whether their expres-
sion is causative, consequential, or correlative for the pluripotent
state. The second set is composed of genes that are up-regulated
upon differentiation, ADRA2C, CXCL12, FRAT2. If these genes
play a role in the undifferentiated state then their up-regulated
expression upon differentiation might indicate that their role in
the differentiated lineages requires higher doses. JUN, however,
showed contradictory behavior as it was up-regulated in the EB-
based differentiation dataset and down-regulated in the OCT3/4
knockdown dataset (Figures 3B,C).
We then decided to test a subset of these factors and applied the
recombinant form of these cytokines or inhibitors of the respec-
tive pathways to human ESCs. First, we tested various concentra-
tions of recombinant cytokines EPHB2 and EPHB3 (100 ng/ml–
5μg/ml each)(data not shown), WNT3A (1–100 ng/ml), IL-11
(1–100 ng/ml), on undifferentiated hES cell line H1 in N2B27
medium (Supplementary Figure 1). We also added the inhibitors
Chalcone4 (10 nM–10μM) that inhibits CXCL12 and thereby
disables the CXCL12-CXCR7 axis. In order to inhibit JUN we
added SP600125 (0.1–50μM) which does inhibit JUN indirectly
by the inhibition of its kinase and activator, C-JUN N-terminal-
Kinase (JNK). After 3 days the cells were stained for Alkaline
Phosphatase (AP) (Supplementary Figure 1). Three days of
bFGF deprivation was sufficient to initiate differentiation. No
effects were observed upon stimulation with WNT3A, EPHB2,
EPHB3, and Chalcone4. However, the SP600125 inhibitor showed
a cytotoxic effect at 30 and 40μM and dramatic toxic effects
at 50μM (Supplementary Figure 1). At 10 and 20μM some
toxic effects were only observed in N2B27 medium, but not in
MEF-conditioned medium. The addition of IL-11 induced the
strongest AP staining at 10 ng/ml.
2.3. IL-11 IS A NOVEL PLURIPOTENCY SUPPORTING GENE
We focused further investigations on IL-11, because treatment of
hESCs with this cytokine exhibited themost promising effect. The
cells were stepwise adapted to grow in medium supplemented
only with IL-11 and cultured on MEFs as feeder cells. First, the
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Table 1 | Candidate models selected for experimental validation.
Cluster ID Candidate gene Proposed regulation Positive regulators Negative regulators
and target
C5 WNT3 −→ ACTA ACTA, BMP4, FGF2, NANOG, OCT3/4 none
C14 CXCL12 −→ ACTA BMP4, GADD45G, OCT3/4, SOX2 ACTA
C15 FUT8 −→ ACTA ACTA, BMP4, FGF2 NANOG, OCT3/4, SOX2
C16 CD99 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C16 CXCR7 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C16 EPHB2 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C16 EPHB3 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C16 MAP7D1 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C16 NEDD9 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C16 PLXNA2 −→ ACTA ACTA, BMP4 NANOG, OCT3/4, SOX2
C28 ADRA2C −→ ACTA ACTA, BMP4, NANOG, OCT3/4, SOX2 none
C36 IL11 −→ ACTA BMP4, FGF2 NANOG, OCT3/4, SOX2
C36 JUN −→ ACTA BMP4, FGF2 NANOG, OCT3/4, SOX2
C39 NRIP1 −→ ACTA ACTA, BMP4, FGF2 OCT3/4, SOX2
C41 FRAT2 —| FGF2 OCT3/4, SOX2 ACTA, BMP4, FGF2
Each model, consisting of cluster ID, proposed regulation and target triplet, is described with its regulators and genes belonging to the cluster.
cells were cultured in 50% MEF-conditioned medium (CM) and
50% unconditioned hES medium (UM). This medium mixture
was supplemented with 10 ng/ml IL-11 instead of bFGF and cul-
tured for two passages. Then, cultured for another two passages
with 10%:90% (CM:UM) and finally in UM only supplemented
with 10 ng/ml IL-11. This strategy succeeded in our hands only
when combined with the application of the ROCK inhibitor
and Thiazovivin, simultaneously. The cells were grown in IL-
11 hESC medium for at least 9 passages not only maintaining
the undifferentiated morphology, but also immunohistochem-
istry experiments showed that the cells were positive for OCT3/4,
SOX2, NANOG, and TRA1-60 (Figures 4, 5).
In order to understand the signaling mechanism of IL-11
in comparison to bFGF signaling in supporting the undif-
ferentiated state we employed microarray-based gene expres-
sion profiling. The hESCs line H9 culture was deprived of
bFGF for 5 days and as negative control compared with the
bFGF supplemented positive control and IL-11 supplemen-
tation as the test of our prediction. Although 5 days were
not long enough to induce dramatic morphological change
upon bFGF withdrawal (Figure 4) early effects of differentiation
could already be studied. OCT3/4 and NANOG immunohisto-
chemistry showed intermediate signal intensities in the IL-11
treated cells in comparison to the negative and positive con-
trols (Figure 5) (full data available as Supplementary Table 1).
The global gene expression as illustrated in the correlation data
(Supplementary Table 2) and hierarchical clustering mirrored
these results. The largest differences appeared between the bFGF
supplemented positive control and the bFGF deprived negative
control, R2 < 0.948 (Supplementary Table 2). The gene expres-
sion profile of the IL-11 treated cells occupied an intermedi-
ate state that is slightly closer to the bFGF deprived control,
0.9838 > R2 > 0.9737 (correlation to bFGF supplemented con-
trol 0.9509 > R2 > 0.9411). Similarly, the hierarchical clustering
reveals also that the IL-11 treatment occupies an intermediate
FIGURE 4 | IL-11 treatment. (A) Morphology of hESCs maintained with
different cytokines—FGF2 (left), IL-11 (middle), and IL-11 plus LIF (right). (B)
Immunocytochemistry for OCT3/4 (columns 1–3) and SOX2 (columns 4–6)
on bFGF treated cells (top row), IL11 treated cells (middle row) and IL11
plus LIF treated cells (bottom row).
state. The fact that the R2 value of the IL-11 treatment is
closer to that of bFGF deprived control than the bFGF treat-
ment might hint toward a potentially distinct mechanism being
employed by IL-11 than by bFGF in supporting the pluripotent
state.
The Venn diagram shows the overlapping and distinct tran-
scriptome signatures whereby 8975 genes were expressed in all
three samples −bFGF, +bFGF and +IL-11 (Figure 6). Amongst
the common expressed genes were also pluripotency markers
like OCT3/4, SOX2, NANOG, because 5 days are not long
enough to induce full differentiation, but long enough to iden-
tify putative direct targets of IL-11. However, in the +bFGF
sample OCT3/4 was more than 2.6 fold higher expressed and
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FIGURE 5 | Immunocytochemistry andphase contrast showing themaintenanceof pluripotencymarker expressionOCT3/4,NANOG, andTRA1-60upon
IL11 application compared to FGF2 positive and negative control and autocrine effect of FGF2 by blocking the FGF receptor with SU5402 after 3 days.
FIGURE 6 | Venn diagram showing distinct and overlapping
transcriptomic signatures of FGF2 (yellow), IL11 (green) treated cells
and non-treated cells (blue).
NANOG more than 1.7 fold higher expressed than in the −bFGF
sample indicating that the differentiation process had been ini-
titated. 239 genes were distinctly expressed in the bFGF treat-
ment and 123 genes upon IL-11 treatment. Another 118 genes
were commonly expressed in the bFGF and in the IL-11 treat-
ment. The lists of the distinct Venn diagram compartments
are found in Supplementary Table 3. KEGG pathway analysis
revealed that the common genes expressed in FGF2 and IL-
11 are enriched for cell adhesion, tight junction, insulin sig-
naling and cancer pathways. In the IL-11 only compartment
we found enrichment for regulation of actin cytoskeleton and
adherens junction (Tables 2, 3). Since IL-11 belongs, like LIF,
to the IL-6 family and both signal via gp130 as co-receptor
we tested whether the addition of murine LIF would have a
beneficial effect. We did not observe morphological differences
between IL-11+LIF and IL-11 only treated cells nor differences
in intensities of immunostainings for OCT3/4 and SOX2
(Figures 4A,B).
Table 2 | KEGG Pathway involvement in commonly expressed genes
in FGF2 and IL-11 treatments.
Pathway Gene p-value Genes
count
Cell adhesion moleculs
(CAM)
4 0.05703 SDC1, CD34, CLDN10,
ICOSLG
Tight junction 4 0.05915 INADL, CLDN10, AKT3,
CTNNB1
Insulin signaling pathway 4 0.06022 TSC1, PRKAR1A,
SOCS4, AKT3
Pathways in cancer 6 0.06459 PDGFA, PML, FGF12,
COL4A6, AKT3,
CTNNB1
Melanoma 3 0.08100 PDGFA, FGF12, AKT3
Table 3 | KEGG pathway involvement enriched for genes expressed in
IL-11 treatments only.
Pathway Gene count p-value Genes
Regulation of actin
cytoskeleton
5 0.05345 PFN2, WASF1, MRAS,
ITGA1, ACTN2
Adherens junction 3 0.09307 WASF1, ACTN2, FARP2
3. DISCUSSION
In this study we used a combination of literature knowledge and
experimental datasets to expand regulatory network of human
embryonic stem cells. Since the identification of core regulatory
triplet of hESCs by (Boyer et al., 2005) many groups have com-
posed pluripotency networks (Muller et al., 2008; Chavez et al.,
2009; Lister et al., 2009; Macarthur et al., 2009; Won et al., 2012).
Most of these networks have been composed using co-expression,
protein-protein interaction or chromatin-immunoprecipitation
studies and more for descriptive than modeling purposes. In
this paper, we used perturbation experiments that reflect reg-
ulatory protein impact on its targets. By doing that we could
evaluate the potential of using only perturbation datasets for
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reconstructing a gene regulatory network as other data types such
as protein-protein interactions or chromatin immunoprecipita-
tion data might be harder to obtain. While connections between
genes in this type of a network cannot be distinguished between
direct and indirect, we can expect the differentially expressed
genes to be downstream targets of the perturbed genes. The
nature of these datasets suit perfectly for boolean modeling as we
just need to define potential direct or indirect regulation between
gene-gene pairs and do not need kinetic constants that are hard
to acquire for a larger gene set. Although perturbation experi-
ments have been previously used by (Amit et al., 2009) to study
how human pathogen-sensing pathways acquire specifity, it is to
our knowledge the first time this approach has been used for
expanding pluripotency governing networks in pluripotent cells.
Of course perturbation-based network can be combined besides
literature knowledge also with other types of gene-gene inter-
action expressing datatypes and with the ever-expanding data
sources it would be potential next step to study the complexity
of pluripotency.
Perturbation experiments are helpful in identifying down-
stream targets of the affected gene and therefore a promising
approach for identifying gene targets in a high-throughput man-
ner. However, it is not possible to do all the potential perturba-
tions for a given cellular system in vitro as the proteins might be
difficult to over-express or the RNAi needed are not known for
genes of interest. Here, in silico modeling comes into play as the
computational perturbation experiments are easy to execute with
a network modeling approach. In this work we created network
models to select a handful of candidate genes to be experimentally
validated from hundreds of cytokine pathway associated factors
that otherwise would have been hard to prioritize.
In order to score the created models we used angles between
eigenvectors from principal component analysis of network activ-
ity states. When the angles are small between eigenvectors then
the variables, in our case pluripotency markers, are correlated.
We used this approach as it is known that the core regulatory cir-
cuit of OCT3/4, SOX2, and NANOG have to be all active in order
to maintain pluripotency and inactivate differentiation-inducing
signals.
Out of the prioritized 15 novel factors that our method pre-
dicted we were able to either supplement or inhibit only 6 genes
(CXCL12, EPHB2, EPHB3, IL-11, JUN, and WNT3A) as for
these genes we were able to find recombinant proteins or known
inhibitors. Out of these 6 genes, we were able to show that IL-11
plays an important role in maintaining pluripotency in hESCs.
A probable reason why the other 5 genes that we were able to
test did not exert such a strong effect might be either that the
concentrations used were sub-optimal or that their effect is not
potent enough to maintain pluripotency. In case of EPHB2 and
EPHB3, which are membrane bound ligands and are involved in
bi-directional signaling, might not fulfill our predicted function
when supplemented in a soluble form as we did.
The known critical genetic factors that govern the pluripo-
tent state in the murine and human system are conserved to a
large extent. For example, the core transcription factors OCT3/4,
SOX2, and NANOG are common to both, the murine and the
human system (Chambers et al., 2003; Boyer et al., 2005; Ying
et al., 2008; Jung et al., 2010) as well as other factors like KLF4,
c-MYC are expressed in both cell types. In fact, their reactivation
in generating induced pluripotent stem cells is essential in both
systems (Takahashi and Yamanaka, 2006; Wernig et al., 2007).
However, it seemed that there are also differences between mESCs
and hESCs. For example the role of signaling pathways is less con-
served. In murine embryonic stem cells (mESCs) the LIF/STAT3
pathway can sustain self-renewal but in serum free conditions the
additional activity of BMP4 is required. LIF independence can
be achieved by FOXP1 ESC specific splice isoform (Gabut et al.,
2011) or by inhibition of the ERK branch of FGF signaling using
the PD0325901 inhibitor supported by inhibition of GSK3 using
CHIR99021 which helps to stabilize β-CATENIN (Ying et al.,
2008). The latter, therefore, attributes supportive effects of WNT
signaling to the pluripotent state. Although, mESCs and hESCs
were considered different in signaling activites, similar observa-
tions were made in hESCs using BIO, another GSK inhibitor.
However, this was only possible in the presence of FGF2 (Sato
et al., 2004). In the hESCs, the LIF/STAT3 pathway fails to show
any supportive effect, and in contrast to the murine ESCs the
ERK signaling is required to mediate bFGF, PDGF, S1P signaling.
Further SMAD2/3 (activated through TGFβ), PI3K/AKT signal-
ing (activated through IGFII) and NFκβ signaling are essential to
maintain the pluripotent state as judged by down-regulation of
these pathways upon embryoid body formation and other func-
tional experiments (Armstrong et al., 2006; Bendall et al., 2007;
Greber et al., 2008). BMP4 induces trophectoderm differentiation
acting via SMAD1/5/8 (Xu et al., 2005b; Sudheer et al., 2012).
These signaling differences became somewhat clearer when it
was realized that mESCs represent a more “naïve” state than the
“primed”mESCs and hESCs (Brons et al., 2007; Tesar et al., 2007).
It is possible to isolate pluripotent murine stem cells from the
ICM and the post-implantation epiblast, a developmentally later
stage. These so called and primed EpiStemCells (EpiSC) behave
very similar to hESCs, ranging from flat colonymorphology, non-
responsive to LIF, and dependence on FGF2 and ACTIVIN A,
sensitivity to single-cell dissociation, X-chromosome inactivation
(XCI), low chimera-contribution (Tesar et al., 2007; Ying et al.,
2008; Hanna et al., 2010; Lengner et al., 2010), etc. Hence, it
appears that the differences between the mESCs and hESCs are
not due to species differences, but are attributable to different
developmental stages. Therefore, it seems justified to speculate
that a human naïve pluripotent counterpart exists. Indeed, Hanna
and colleagues showed for a short period of twenty passages that
it was possible to force human pluripotent stem cells to adopt a
naïve phenotype (Hanna et al., 2010). mEpiSCs, which are sim-
ilar to hESCs, require FGF/ERK signaling for both maintaining
the pluripotent state and preventing from falling back into the
naïve state (Kunath et al., 2007; Nichols et al., 2009; Lanner and
Rossant, 2010). Identifying IL-11 as a pluripotency promoting
factor in human ESCs renders the signaling differences between
the human andmurine pluripotent systems that are largely accen-
tuated by the role played by LIF in the murine naïve, but not in
the human “primed” system, as less pronounced as previously
thought. Nonetheless, for other mechanisms it is known that they
act in synergy, e.g., on establishing pregnancy (Dimitriadis et al.,
2010).
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Our discovery that IL-11 can replace exogenous FGF2 may
represent a stepping stone for interconverting the two pluripo-
tent states, naïve and primed, and thereby potentially be the first
step from releasing the primed cells from bFGF dependency to
pave the way for de-differentiation to the naïve state. In line with
this hypothesis is that LIF and IL-11 belong to the IL-6 fam-
ily and signal through the same co-receptor gp130 (Nandurkar
et al., 1996; Timmermann et al., 2000). Although in our study
we did not observe any effects upon LIF treatment, we cannot
exclude a potential role for LIF, because we applied the murine
LIF (mLIF) instead of the human LIF (hLIF). Both are highly
conserved, but there are slight variations which could affect their
function. In fact, Daheron and colleagues showed that hLIF leads
to STAT3 phosphorylation in mESCs while mLIF fails to activate
human STAT3 (Daheron et al., 2004). Further, the study of Hanna
and others showed at least transionary that hLIF can support the
human pluripotent state (Hanna et al., 2010).
If IL-11 indeed aids in the conversion of the primed to the
naïve state or stabilizes the primed pluripotent state, then it seems
incapable of fulfilling this role on its own. It might require the
support from other factors for several reasons. First, the IL-11
treatment resulted in a gene expression signature that is closer to
the FGF untreated state and the expression intensities of OCT3/4
and SOX2 are intermediate as well. Second, morphologically we
did not observe colony similarities to the naïve state. Third, the
IL-11 treatment is hypersensitive to single cell dissociation, as
judged by the requirement of ROCK and Thiazovivin simultane-
ously. Presumably, it’s also still in an XaXi state instead of an XaXa
which has to be addressed experimentally.
The question still remains, what are the mechanisms employed
by IL-11 and FGF2 to sustain the pluripotent state? The mech-
anism employed by bFGF acts on the mouse embryonic feeder
cells or when cultured on matrigel on the hESC derived fibrob-
last like support cells (autologous feeders) to produce and release
supportive factors for the maintenance of undifferentiated hESCs
(Greber et al., 2007a). Some of these factors are TGFB1, INHBA,
IGFII (in order to activate MEK/ERK and PI3K/AKT signaling)
and the BMP4 antagonists CER1 and GREM1 to avoid induction
of differentiation via SMAD1/5/8 (Bendall et al., 2007; Greber
et al., 2008). Further downstream targets of bFGF are transcrip-
tion factors involved in proliferation such as c-FOS, c-JUN, MYC,
and ETS2 (Greber et al., 2007a). Also IL-11 was up-regulated
which is traditionally known to be involved in proliferation in
the hematopoetic system (Nandurkar et al., 1998). Like the bFGF
pathway, the inhibition of TGFβ which acts via SMAD2/3 sig-
naling induces differentiation in hESCs (Greber et al., 2008),
PI3K/AKT signaling is repressed upon embryoid body formation
(Armstrong et al., 2006) and it was discovered that IGFII initi-
ates this signaling pathway by binding to IGFR1 (Wang et al.,
2005). In the same study, the authors demonstrated that the IGFII
pathway seems to be more dominant than the bFGF pathway.
They demonstrated that the addition of IGFII and FGFR inhibitor
couldmaintain the undifferentiated state whereas vice versa it was
not possible. The pathways of PI3K/AKT and MEK/ERK cross-
talk through GSK3, because AKT phosphorylates and inactivates
GSK3α and GSK3β. Also, the PI3K/AKT pathway cross-talks
with the NFκβ pathway. AKT phosphorylates Iκβ, the cytosolic
inhibitor of κβ (NFκβ). There are indications that the NFκβ path-
way acts upstream of the MEK/ERK pathway. IL-11 seems to
employ different mechanisms, as our data indicate. The R2 val-
ues of the IL-11 treatment are closer to the bFGF deprived control
than the bFGF treatment. In terms of gene expression, this might
be a hint of a global dimension that a distinct mechanism is being
employed. More specific mechanisms are indicated by the acti-
vated pathways of adherens junction and the actin cytoskeleton,
which was implicated by Thomson and his colleagues (Chen et al.,
2010) to be associated with the pluripotent state. The cytoskele-
tal involvement is very clear when the ROCK inhibitor is used
on single cell suspension blocking the myosin-actin mediated
contraction of hESC and thus ensuring survival (Chen et al.,
2010).
It appears that the bFGF and IL-11 mediated promotions of
pluripotency belong to independent mechanisms and it might
be justified to speculate that the combined application of both
might lead to additive reinforcement of self-renewal and pluripo-
tency (which ever this might be—naïve or primed) by stabilizing
MEK/ERK and the activation of the actin cytoskeleton pathway,
respectively. However, in order to convert hESCs into a naïve
state or to stabilize the primed state even further in a FGF2-
independent manner, additional supporting cytokine, inhibitors
or conditions need to be found to strengthen the effect of IL-11,
because to date it appears as if bFGF traps the primed pluripotent
state by preventing differentiation and further de-differentiation
(Thomson et al., 1998; Li et al., 2009; Greber et al., 2010; Hanna
et al., 2010). These insights will have substantial implications
both on the iPS cells and deepen our understanding of pluripo-
tent substates. Taken together our study shows that our combined
approach of systems biology and experimental biology can iden-
tify factors that are counterintuitive and, hence, hard to discover
otherwise. Equally important, this approach can be applied to any
other cellular system and thereby enhance research progress.
4. MATERIALS AND METHODS
4.1. IDENTIFICATION OF CANDIDATE GENES USING QUALITATIVE
MODELING
The initial literature based network was very limited and com-
posed of bFGF/MEK/ERK/NANOG (Xu et al., 2008) signaling
as well as TGFβ1, ACTIVIN, NODAL/SMAD2/3/NANOG (Xu
et al., 2008) in competition with BMP4/SMAD1/5/8 which drives
differentiation (Xu et al., 2002). This configuration of signaling
cascades was thought to maintain the expression of the key fac-
tors of the pluripotent state OCT3/4, SOX2, and NANOG which
are transcription factors that form multiheteromers in different
combinations, but also bind their target genes individually (Boyer
et al., 2005). Knock down experiments, i.e., of OCT3/4, showed
that hCG and GCM1 are directly or indirectly negatively reg-
ulated by OCT3/4 (Matin et al., 2004). In addition GADD45G
and BMP4 have been shown to be negatively regulated by OCT4
(Babaie et al., 2007) and are direct targets of OCT4 (Jung et al.,
2010).
We expanded the initial literature network by using gene per-
turbation data from Embryonic Stem Cell Database (Jung et al.,
2010).OCT3/4, SOX2, andNANOGRNAi knockdowns in human
embryonal carcinoma cells (NCCIT) are from (Greber et al.,
www.frontiersin.org October 2013 | Volume 4 | Article 303 | 9
Peterson et al. hESC qualitative modeling
2007b). Protein supplementation experiments of bFGF, BMP4,
and ACTIVIN A in human H1 embryonic stem cells originates
from (Greber et al., 2008) and GADD45G addition experiment in
NCCIT cells was described by (Jung et al., 2010) (Figure 2B).
Edges in the expanded network were defined by the pertur-
bation expriments in the following manner: genes that showed
significant expression change (at least 1.5 fold change in log2 scale
with p-value less than 1.0e-05; detection p-value less than 1.0e-05)
after the perturbation were added to the network. Genes showing
up-regulation after adding the protein gained positive incom-
ing edge, while genes showing down-regulation gained negative
incoming edge. The opposite applies for negative perturbation
experiments of RNAi knockdowns.
In order to limit the search space of possible important regula-
tors, we first concentrated on genes that had at least five incoming
edges from the core regulators. This enabled to keep only these
genes that are under strong regulation of known regulators and
therefore more likely to be important for given cellular states.
Secondly, we considered only genes that are either receptors or
ligands by including only genes belonging to cell surface recep-
tor linked signaling pathway (GO:0007166) and receptor binding
(GO:0005102) Gene Ontology categories. This filtering served the
purpose to identify candidate genes that could be more easily
validated experimentally. Finally, genes having identical incom-
ing regulatory edges were clustered together to a node in order
to reduce the network size, thus forming a reduced perturbation
network (Figure 2C). All possible network sizes and respective
running times are shown in Supplementary Table 4.
We composed models by introducing a new regulatory edge to
the reduced perturbation network. The edge is added from a ter-
minal node (cluster, having only incoming edges) to any regulator
(nodes from initial literature network having outgoing edges)
in the network. The edge can be either activating or inhibiting.
Each model represents a network that differs from the reduced
perturbation network by only an added edge (Figure 2E).
Using these model networks we performed in silico perturba-
tion experiments using boolSim (version 1.0) program developed
by Garg et al. (2009). boolSim was run in synchronous mode
where all nodes change values simultaneously in sequential time
points. We did not set a limit for the number of steps to be done
before falling into steady states. The parameters we used were -p
with value 1 for synchronous mode; -f for input network file; -o
for output of identified steady states; -e specifying the perturbed
node and type of perturbation (over-expression or knockdown)
. We performed for all regulatory nodes in each model network
both over-expression and knockdown experiments. Each in sil-
ico perturbation experiment leads to zero or more steady states
which express the potential activation and inactivation status of
our model network. We consider as steady states both fixed and
strongly connected steady states, where subsets of the network
nodes might be in cyclic steady states. Such states can be described
as binary vectors where 1 marks active and 0 a passive mode of
each node in the network. These vectors were next merged into
a steady state matrix where each row represents one steady state
and each column represents a node in the network.
In order to score the models we defined OCT3/4, SOX2,
and NANOG as pluripotency marker genes. As differentiation
markers we used BMP4 as it is known to induce the differ-
entiation of human ES cells to trophoblast (Xu et al., 2005b)
and GADD45G that is known to activate differentation pathways
(Jung et al., 2010).
In the assessment step we reduced the dimensions of the steady
state matrix with principal component analysis using the latest
version of prcomp package (Venables and Ripley, 2002) in R ver-
sion 2.13.0 (R Development Core Team, 2011). In this analysis
the first principal component, PC1, represents the direction of the
highest variance of the data and the second principal component,
PC2, represents the highest remaining variance orthogonal to the
first component. We used the first two principal components
to define a vector for each marker gene and calculated angles
between such vectors to score our model networks. Resulting
angles are small between same state markers (either pluripo-
tency markers OCT3/4, SOX2, and NANOG; or differentiation
markers BMP4 and GADD45G) and large between different states
when the model represents a regulatory network where same
cell state markers (e.g., BMP4 and GADD45G) are in one state
(e.g., inactivated) and the second state markers (e.g., OCT3/4,
SOX2, and NANOG) are in the opposite state (e.g., activated).
Each of the models is therefore scored by three different angles
and models having minimal angle between pluripotency mark-
ers and having maximal angle between pluripotency markers
and differentiation markers were selected for experimental testing
(Figure 3A).
4.2. CELL CULTURE
Human ESCs were maintained on Mytomycin C inactivated
mouse MEFs in KnockOut DMEM (Invitrogen) supplemented
with 20% KnockOut serum replacement (Invitrogen), 0.1mM
non-essential amino acids (Invitrogen), 1mM L-glutamine
(Invitrogen), 0.1mM β-mercaptoethanol (Sigma), 8 ng/ml bFGF
(Invitrogen). For passaging, hESCs and cells were split 1:3 using
1mg/ml collagenase IV (Invitrogen). Alternatively, for feeder-free
culture, hESCs cells were plated on Matrigel (Becton Dickinson)-
coated plate in MEF-conditioned medium supplemented with
8 ng/ml bFGF or in N2B27 medium supplemented with 24 ng/ml
bFGF. The SP600125 (Sigma) inhibitor was dissolved in DMSO
and added to the cells to a final concentration of 5 or 10μM.
Recombinant IL-11 (Sigma) was added to a final concentration
of 10 ng/ml and murine LIF 103 Units/ml (Millipore).
4.3. ALKALINE PHOSPHATASE STAINING AND
IMMUNOFLUORESCENCE STAINING
Alkaline phosphatase staining was performed using the alkaline
phosphatase detection kit (Millipore) according to the manufac-
turer’s protocol. For immunofluorescence staining, the cells were
fixed in 4 % paraformaldehyde in PBS for 15min, permeabilized
using 0.1 % Triton X-100 (Sigma) for 30min at RT and blocked
with 5% chicken or fetal calf serum for 30min. Subsequently,
the cells were incubated with the primary antibodies in blocking
solution overnight at 4◦C. The primary antibodies includedmon-
oclonal antibodies against OCT3/4 (Santa Crutz, 1:100), SOX2
(Santa Cruz, 1:100), NANOG (Abcam, 1:500), SSEA-1 (Millipore,
1:500), SSEA-3 (Abcam, 1:500), SSEA-4 (Abcam, 1:500), TRA-1-
60 (Millipore, 1:500), TRA-1-81 (Millipore, 1:500).
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4.4. MICROARRAY ANALYSIS
Total RNA was extracted using the MiniRNeasy Kit accord-
ing to the manufacturer’s protocol. The quality was checked by
Nanodrop analysis (Nanodrop Technologies). 500 ng were used
for biotin-labeled cRNA production using a linear amplification
kit (Ambion). Hybridizations, washing, Cy3-streptavidin stain-
ing, and scanning were performed on the Illumina BeadStation
500 platform (Illumina) according to manufacturer’s instruc-
tion. cRNA samples were hybridized onto Illumina human-8
BeadChips version 3. All basic gene expression data analyses
were carried out using the BeadStudio software 3.0. Raw data
were background-subtracted, normalized using the rank invari-
ant algorithm and then filtered for significant expression on the
basis of negative control beads. Pathway analyses were determined
according to Gene Ontology terms or mapped to KEGG path-
ways (Kanehisa et al., 2012) and BIOCARTA pathways (http://
www.biocarta.com/genes/index.asp) with DAVID 2006 (Huang
et al., 2009a,b) using GenBank accession numbers represented
by the corresponding chip oligonucleotides as input. Then gene
expression arrays (Illumina) for genome-wide expression analysis
was carried out. The expression data have been deposited in the
Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.
gov/geo (accession no. GSE51159).
4.5. STATISTICAL ANALYSIS
A groups comparison of two were made using Student’s two-
tailed t-test. Data represent the mean of triplicates and are
expressed as mean and standard deviation. All statistical analyses
were performed using the SPSS 6.0 statistical software program.
P-values of< 0.05 were considered statistically significant.
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Supplementary Figure 1 | Raw data of initial alkaline phosphatase screen
of predicted candidate genes for 3 days. Shown are four 12 well plates,
each testing various concentrations of the predicted candidate cytokines
or inhibitors of the respective pathway. Top left, WNT3A 1–100 ng/ml. Top
right, Chalcone4 (inhibiting the CXCL12—CXCR7 axis) 10 nM–10 μM.
Bottom left, IL-11 1–500 ng/ml. Bottom right, SP600125 (inhibiting JNK
which in turn fails to activate c-JUN) tested at concentrations ranging from
0.1 to 50μM. Pink arrows show DMSO control, red arrows show water
control and the green arrows the SP600125 at 50μM.
Supplementary Table 1 | Illumina expression data of ES cells treated with
and without FGF2 and IL-11.
Supplementary Table 2 | The global gene expression as illustrated in the
correlation data.
Supplementary Table 3 | The lists of the distinct Venn diagram
compartments.
Supplementary Table 4 | Various network sizes and corresponding
calculation times.
REFERENCES
Amit, I., Garber, M., Chevrier, N., Leite,
A. P., Donner, Y., Eisenhaure, T., et
al. (2009). Unbiased reconstruc-
tion of a mammalian transcrip-
tional network mediating pathogen
responses. Science 326, 257–263.
doi: 10.1126/science.1179050
Amit, M., Chebath, J., Margulets, V.,
Laevsky, I., Miropolsky, Y., Shariki,
K., et al. (2010). Suspension
culture of undifferentiated human
embryonic and induced pluripo-
tent stem cells. Stem Cell Rev. 6,
248–259. doi: 10.1007/s12015-010-
9149-y
Andrews, P. W., Fenderson, B., and
Hakomori, S. (1987). Human
embryonal carcinoma cells and their
differentiation in culture. Int. J.
Androl. 10, 95–104. doi: 10.1111/j.
1365-2605.1987.tb00170.x
Armstrong, L., Hughes, O., Yung, S.,
Hyslop, L., Stewart, R., Wappler, I.,
et al. (2006). The role of PI3K/AKT,
MAPK/ERK and NFkappabeta
signalling in the maintenance
of human embryonic stem cell
pluripotency and viability high-
lighted by transcriptional profiling
and functional analysis. Hum. Mol.
Genet. 15, 1894–1913. doi: 10.1093/
hmg/ddl112
Babaie, Y., Herwig, R., Greber, B.,
Brink, T. C., Wruck, W., Groth,
D., et al. (2007). Analysis of
Oct4-dependent transcriptional
networks regulating self-renewal
and pluripotency in human embry-
onic stem cells. Stem Cells 25,
500–510. doi: 10.1634/stemcells.20
06-0426
Bahrami, A. R., Matin, M. M., and
Andrews, P. W. (2005). The CDK
inhibitor p27 enhances neural
differentiation in pluripotent
NTERA2 human EC cells, but
does not permit differentiation of
2102Ep nullipotent human EC cells.
Mech. Dev. 122, 1034–1042. doi:
10.1016/j.mod.2005.04.011
Bendall, S. C., Stewart, M. H.,
Menendez, P., George, D.,
Vijayaragavan, K., Werbowetski-
Ogilvie, T., et al. (2007). IGF
and FGF cooperatively establish
the regulatory stem cell niche
of pluripotent human cells in
vitro. Nature 448, 1015–1021. doi:
10.1038/nature06027
Bigdeli, N., Andersson, M., Strehl,
R., Emanuelsson, K., Kilmare, E.,
Hyllner, J., et al. (2008). Adaptation
of human embryonic stem cells to
feeder-free and matrix-free culture
conditions directly on plastic sur-
faces. J. Biotechnol. 133, 146–153.
doi: 10.1016/j.jbiotec.2007.08.045
Bonzanni, N., Garg, A., Feenstra,
K. A., Schutte, J., Kinston, S.,
Miranda-Saavedra, D., et al. (2013).
Hard-wired heterogeneity in
blood stem cells revealed using a
dynamic regulatory network model.
Bioinformatics 29, i80–i88. doi:
10.1093/bioinformatics/btt243
Boyer, L. A., Lee, T. I., Cole, M. F.,
Johnstone, S. E., Levine, S. S.,
Zucker, J. P., et al. (2005). Core
transcriptional regulatory circuitry
www.frontiersin.org October 2013 | Volume 4 | Article 303 | 11
Peterson et al. hESC qualitative modeling
in human embryonic stem cells.
Cell 122, 947–956. doi: 10.1016/j.
cell.2005.08.020
Brons, I. G., Smithers, L. E., Trotter,
M. W., Rugg-Gunn, P., Sun, B.,
Chuva de Sousa Lopes, S. M.,
et al. (2007). Derivation of
pluripotent epiblast stem cells from
mammalian embryos. Nature
448, 191–195. doi: 10.1038/nature
05950
Brown, S., Teo, A., Pauklin, S., Hannan,
N., Cho, C. H., Lim, B., et al.
(2011). Activin/Nodal signaling
controls divergent transcriptional
networks in human embryonic stem
cells and in endoderm progeni-
tors. Stem Cells 29, 1176–1185. doi:
10.1002/stem.666
Chambers, I., Colby, D., Robertson,
M., Nichols, J., Lee, S., Tweedie,
S., et al. (2003). Functional
expression cloning of Nanog, a
pluripotency sustaining factor in
embryonic stem cells. Cell 113,
643–655. doi: 10.1016/S0092-8674
(03)00392-1
Chavez, L., Bais, A. S., Vingron, M.,
Lehrach, H., Adjaye, J., and Herwig,
R. (2009). In silico identifi-
cation of a core regulatory net-
work of OCT4 in human embry-
onic stem cells using an integrated
approach. BMC Genomics 10:314.
doi: 10.1186/1471-2164-10-314
Chen, G., Gulbranson, D. R., Hou, Z.,
Bolin, J. M., Ruotti, V., Probasco,
M. D., et al. (2011). Chemically
defined conditions for human
iPSC derivation and culture.
Nat. Methods 8, 424–429. doi:
10.1038/nmeth.1593
Chen, G., Hou, Z., Gulbranson, D. R.,
and Thomson, J. A. (2010). Actin-
myosin contractility is responsible
for the reduced viability of dissoci-
ated human embryonic stem cells.
Cell Stem Cell 7, 240–248. doi:
10.1016/j.stem.2010.06.017
Daheron, L., Opitz, S. L., Zaehres,
H., Lensch, M. W., Lensch, W. M.,
Andrews, P. W., et al. (2004).
LIF/STAT3 signaling fails to main-
tain self-renewal of human embry-
onic stem cells. Stem Cells 22,
770–778. doi: 10.1634/stemcells.22-
5-770
Dimitriadis, E., Menkhorst, E.,
Salamonsen, L. A., and Paiva,
P. (2010). Review: LIF and IL11
in trophoblast-endometrial inter-
actions during the establishment
of pregnancy. Placenta 31(Suppl.),
99–104. doi: 10.1016/j.placenta.
2009.12.027
Enver, T., Soneji, S., Joshi, C., Brown, J.,
Iborra, F., Orntoft, T., et al. (2005).
Cellular differentiation hierarchies
in normal and culture-adapted
human embryonic stem cells, Hum.
Mol. Genet. 14, 3129–3140. doi:
10.1093/hmg/ddi345
Fathi, A., Pakzad, M., Taei, A., Brink,
T. C., Pirhaji, L., Ruiz, G., et al.
(2009). Comparative proteome
and transcriptome analyses of
embryonic stem cells during embry-
oid body-based differentiation.
Proteomics 9, 4859–4870. doi:
10.1002/pmic.200900003
Flottmann, M., Scharp, T., and
Klipp, E. (2012). A stochastic
model of epigenetic dynamics
in somatic cell reprogram-
ming. Front. Physiol. 3:216.
doi: 10.3389/fphys.2012.00216
Gabut, M., Samavarchi-Tehrani,
P., Wang, X., Slobodeniuc, V.,
O’Hanlon, D., Sung, H. K., et al.
(2011). An alternative splicing
switch regulates embryonic stem
cell pluripotency and reprogram-
ming. Cell 147, 132–146. doi:
10.1016/j.cell.2011.08.023
Garg, A., Mohanram, K., Di Cara, A.,
De Micheli, G., and Xenarios, I.
(2009). Modeling stochasticity and
robustness in gene regulatory net-
works. Bioinformatics 25, i101–i109.
doi: 10.1093/bioinformatics/btp214
Greber, B., Lehrach, H., and Adjaye, J.
(2007a). Fibroblast growth factor
2 modulates transforming growth
factor beta signaling in mouse
embryonic fibroblasts and human
ESCs (hESCs) to support hESC self-
renewal. Stem Cells 25, 455–464.
doi: 10.1634/stemcells.2006-0476
Greber, B., Lehrach, H., and Adjaye,
J. (2007b). Silencing of core
transcription factors in human EC
cells highlights the importance of
autocrine FGF signaling for self-
renewal. BMC Dev. Biol. 7:46. doi:
10.1186/1471-213X-7-46
Greber, B., Lehrach, H., and Adjaye, J.
(2008). Control of early fate deci-
sions in human ES cells by distinct
states of TGFbeta pathway activity.
Stem Cells Dev. 17, 1065–1077. doi:
10.1089/scd.2008.0035
Greber, B., Wu, G., Bernemann, C., Joo,
J. Y., Han, D.W., Ko, K., et al. (2010).
Conserved and divergent roles of
FGF signaling in mouse epiblast
stem cells and human embryonic
stem cells. Cell Stem Cell 6, 215–226.
doi: 10.1016/j.stem.2010.01.003
Hanna, J., Cheng, A. W., Saha, K.,
Kim, J., Lengner, C. J., Soldner,
F., et al. (2010). Human embry-
onic stem cells with biological and
epigenetic characteristics similar to
those of mouse ESCs. Proc. Natl.
Acad. Sci. U.S.A. 107, 9222–9227.
doi: 10.1073/pnas.1004584107
Huang, D. W., Sherman, B. T.,
and Lempicki, R. A. (2009a).
Bioinformatics enrichment tools:
paths toward the comprehensive
functional analysis of large gene
lists. Nucleic Acids Res. 37, 1–13.
doi: 10.1093/nar/gkn923
Huang, D. W., Sherman, B. T., and
Lempicki, R. A. (2009b). Systematic
and integrative analysis of large gene
lists using DAVID bioinformatics
resources. Nat. Protoc. 4, 44–57. doi:
10.1038/nprot.2008.211
James, D., Levine, A. J., Besser, D.,
and Hemmati-Brivanlou, A. (2005).
TGFbeta/activin/nodal signaling is
necessary for the maintenance of
pluripotency in human embryonic
stem cells. Development 132, 1273–
1282. doi: 10.1242/dev.01706
Josephson, R., Ording, C. J., Liu,
Y., Shin, S., Lakshmipathy, U.,
Toumadje, A., et al. (2007).
Qualification of embryonal car-
cinoma 2102Ep as a reference
for human embryonic stem cell
research. Stem Cells 25, 437–446.
doi: 10.1634/stemcells.2006-0236
Jung, M., Peterson, H., Chavez, L.,
Kahlem, P., Lehrach, H., Vilo, J.,
et al. (2010). A data integra-
tion approach to mapping OCT4
gene regulatory networks opera-
tive in embryonic stem cells and
embryonal carcinoma cells. PLoS
ONE 5:e10709. doi: 10.1371/jour-
nal.pone.0010709
Kalmar, T., Lim, C., Hayward, P.,
Munoz-Descalzo, S., Nichols, J.,
Garcia-Ojalvo, J., et al. (2009).
Regulated fluctuations in nanog
expression mediate cell fate deci-
sions in embryonic stem cells. PLoS
Biol. 7:e1000149. doi: 10.1371/jour-
nal.pbio.1000149
Kanehisa, M., Goto, S., Sato, Y.,
Furumichi, M., and Tanabe, M.
(2012). KEGG for integration
and interpretation of large-scale
molecular data sets. Nucleic
Acids Res. 40, D109–D114. doi:
10.1093/nar/gkr988
Kang, H. B., Kim, J. S., Kwon, H. J.,
Nam, K. H., Youn, H. S., Sok,
D. E., et al. (2005). Basic fibroblast
growth factor activates ERK and
induces c-fos in human embry-
onic stem cell line MizhES1.
Stem Cells Dev. 14, 395–401. doi:
10.1089/scd.2005.14.395
Kim, J., Chu, J., Shen, X., Wang, J.,
and Orkin, S. H. (2008). An
extended transcriptional network
for pluripotency of embryonic stem
cells. Cell 132, 1049–1061. doi:
10.1016/j.cell.2008.02.039
Kunath, T., Saba-El-Leil, M. K.,
Almousailleakh, M., Wray, J.,
Meloche, S., and Smith, A. (2007).
FGF stimulation of the Erk1/2 sig-
nalling cascade triggers transition
of pluripotent embryonic stem
cells from self-renewal to lineage
commitment. Development 134,
2895–2902. doi: 10.1242/dev.02880
Lanner, F., and Rossant, J. (2010).
The role of FGF/Erk sig-
naling in pluripotent cells.
Development 137, 3351–3360.
doi: 10.1242/dev.050146
Lengner, C. J., Gimelbrant, A. A.,
Erwin, J. A., Cheng, A. W.,
Guenther, M. G., Welstead, G. G., et
al. (2010). Derivation of pre-X inac-
tivation human embryonic stem
cells under physiological oxygen
concentrations. Cell 141, 872–883.
doi: 10.1016/j.cell.2010.04.010
Levenstein, M. E., Ludwig, T. E., Xu,
R. H., Llanas, R. A., VanDenHeuvel-
Kramer, K., Manning, D., et al.
(2006). Basic fibroblast growth
factor support of human embry-
onic stem cell self-renewal.
Stem Cells 24, 568–574. doi:
10.1634/stemcells.2005-0247
Li, Y., Powell, S., Brunette, E.,
Lebkowski, J., and Mandalam,
R. (2005). Expansion of human
embryonic stem cells in defined
serum-free medium devoid
of animal-derived products.
Biotechnol. Bioeng. 91, 688–698. doi:
10.1002/bit.20536
Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y.,
Lin, T., et al. (2009). Generation of
rat and human induced pluripotent
stem cells by combining genetic
reprogramming and chemical
inhibitors, Cell Stem Cell 4, 16–19.
doi: 10.1016/j.stem.2008.11.014
Lister, R., Pelizzola, M., Dowen, R. H.,
Hawkins, R. D., Hon, G., Tonti-
Filippini, J., et al. (2009). Human
DNAmethylomes at base resolution
show widespread epigenomic differ-
ences. Nature 462, 315–322. doi:
10.1038/nature08514
Ludwig, T. E., Levenstein, M. E., Jones,
J. M., Berggren, W. T., Mitchen,
E. R., Frane, J. L., et al. (2006).
Derivation of human embryonic
stem cells in defined conditions.
Nat. Biotechnol. 24, 185–187. doi:
10.1038/nbt1177
Macarthur, B. D., Ma’ayan, A., and
Lemischka, I. R. (2009). Systems
biology of stem cell fate and cel-
lular reprogramming. Nat. Rev.
Mol. Cell Biol. 10, 672–681. doi:
10.1038/nrm2766
Matin, M. M., Walsh, J. R., Gokhale,
P. J., Draper, J. S., Bahrami, A. R.,
Morton, I., et al. (2004). Specific
knockdown of Oct4 and beta2-
microglobulin expression by RNA
interference in human embryonic
stem cells and embryonic carcinoma
cells. Stem Cells 22, 659–668. doi:
10.1634/stemcells.22-5-659
Frontiers in Physiology | Systems Biology October 2013 | Volume 4 | Article 303 | 12
Peterson et al. hESC qualitative modeling
Milo, R., Shen-Orr, S., Itzkovitz, S.,
Kashtan, N., Chklovskii, D., and
Alon, U. (2002). Network motifs:
simple building blocks of complex
networks. Science 298, 824–827. doi:
10.1126/science.298.5594.824
Muller, F. J., Laurent, L. C., Kostka, D.,
Ulitsky, I., Williams, R., Lu, C., et al.
(2008). Regulatory networks define
phenotypic classes of human stem
cell lines. Nature 455, 401–405. doi:
10.1038/nature07213
Nandurkar, H. H., Hilton, D. J.,
Nathan, P., Willson, T., Nicola,
N., and Begley, C. G. (1996). The
human IL-11 receptor requires
gp130 for signalling: demonstra-
tion by molecular cloning of the
receptor. Oncogene 12, 585–593.
Nandurkar, H. H., Robb, L., and Begley,
C. G. (1998). The role of IL-II
in hematopoiesis as revealed by a
targeted mutation of its receptor.
Stem Cells 16(Suppl. 2), 53–65. doi:
10.1002/stem.5530160708
Nichols, J., Silva, J., Roode, M., and
Smith, A. (2009). Suppression
of Erk signalling promotes ground
state pluripotency in the mouse
embryo. Development 136, 3215–
3222. doi: 10.1242/dev.038893
R Development Core Team. (2011).
R: A Language and Environment
for Statistical Computing. Vienna:
R Foundation for Statistical
Computing. ISBN 3-900051-07-0.
Remy, E., Ruet, P., Mendoza, L.,
Thieffry, D., and Chaouiya, C.
(2006). “From logical regula-
tory graphs to standard petri
nets: dynamical roles and func-
tionality of feedback citrcuits,”
in LNCS, (Berlin; Heidelberg:
Springer-Verlag), 56–72. doi:
10.1007/11905455_3
Rosler, E. S., Fisk, G. J., Ares, X.,
Irving, J., Miura, T., Rao, M. S.,
et al. (2004). Long-term culture
of human embryonic stem cells in
feeder-free conditions. Dev. Dyn.
229, 259–274. doi: 10.1002/dvdy.
10430
Sato, N., Meijer, L., Skaltsounis, L.,
Greengard, P., and Brivanlou, A. H.
(2004). Maintenance of pluripo-
tency in human and mouse embry-
onic stem cells through activation of
Wnt signaling by a pharmacological
GSK-3-specific inhibitor. Nat. Med.
10, 55–63. doi: 10.1038/nm979
Singh, A. M., Reynolds, D., Cliff, T.,
Ohtsuka, S., Mattheyses, A. L., Sun,
Y., et al. (2012). Signaling network
crosstalk in human pluripotent
cells: a Smad2/3-regulated switch
that controls the balance between
self-renewal and differentiation.
Cell Stem Cell 10, 312–326. doi:
10.1016/j.stem.2012.01.014
Sudheer, S., Bhushan, R., Fauler,
B., Lehrach, H., and Adjaye, J.
(2012). FGF inhibition directs
BMP4-mediated differentiation of
human embryonic stem cells to
syncytiotrophoblast. Stem Cells
Dev. 21, 2987–3000. doi: 10.1089/
scd.2012.0099
Takahashi, K., and Yamanaka, S.
(2006). Induction of pluripotent
stem cells from mouse embryonic
and adult fibroblast cultures by
defined factors. Cell 126, 663–676.
doi: 10.1016/j.cell.2006.07.024
Tesar, P. J., Chenoweth, J. G., Brook,
F. A., Davies, T. J., Evans, E. P.,Mack,
D. L., et al. (2007). New cell lines
from mouse epiblast share defin-
ing features with human embryonic
stem cells. Nature 448, 196–199. doi:
10.1038/nature05972
Thomson, J. A., Itskovitz-Eldor, J.,
Shapiro, S. S., Waknitz, M. A.,
Swiergiel, J. J., et al. (1998).
Embryonic stem cell lines derived
from human blastocysts. Science
282, 1145–1147. doi: 10.1126/
science.282.5391.1145
Timmermann, A., Pflanz, S.,
Grotzinger, J., Kuster, A., Kurth, I.,
Pitard, V., et al. (2000). Different
epitopes are required for gp130
activation by interleukin-6, onco-
statin M and leukemia inhibitory
factor. FEBS Lett. 468, 120–124. doi:
10.1016/S0014-5793(00)01205-9
Vallier, L., Alexander, M., and Pedersen,
R. A. (2005). Activin/Nodal and
FGF pathways cooperate to main-
tain pluripotency of human embry-
onic stem cells. J. Cell. Sci. 118,
4495–4509. doi: 10.1242/jcs.02553
Vallier, L., Touboul, T., Brown, S.,
Cho, C., Bilican, B., Alexander, M.,
et al. (2009). Signaling path-
ways controlling pluripotency and
early cell fate decisions of human
induced pluripotent stem cells. Stem
Cells 27, 2655–2666. doi: 10.1002/
stem.199
Venables, W. N., and Ripley, B. D.
(2002). Modern Applied Statistics
with S, 4th Edn. New York, NY:
Springer. ISBN 0-387-95457-0. doi:
10.1007/978-0-387-21706-2
Wang, J., Rao, S., Chu, J., Shen, X.,
Levasseur, D. N., Theunissen, T. W.,
et al. (2006). A protein interaction
network for pluripotency of embry-
onic stem cells. Nature 444, 364–
368. doi: 10.1038/nature05284
Wang, L., Li, L., Menendez, P., Cerdan,
C., and Bhatia, M. (2005). Human
embryonic stem cells maintained in
the absence of mouse embryonic
fibroblasts or conditioned media are
capable of hematopoietic develop-
ment. Blood 105, 4598–4603. doi:
10.1182/blood-2004-10-4065
Wang, L., Schulz, T. C., Sherrer, E. S.,
Dauphin, D. S., Shin, S., Nelson,
A. M., et al. (2007). Self-renewal
of human embryonic stem cells
requires insulin-like growth factor-1
receptor and ERBB2 receptor sig-
naling. Blood 110, 4111–4119. doi:
10.1182/blood-2007-03-082586
Wang, Y., Xu, Z., Jiang, J., Xu, C.,
Kang, J., Xiao, L., et al. (2013).
Endogenous miRNA sponge
lincRNA-RoR regulates Oct4,
Nanog, and Sox2 in human embry-
onic stem cell self-renewal. Dev. Cell
25, 69–80. doi: 10.1016/j.devcel.
2013.03.002
Wernig, M., Meissner, A., Foreman,
R., Brambrink, T., Ku, M.,
Hochedlinger, K., et al. (2007).
In vitro reprogramming of fibrob-
lasts into a pluripotent ES-cell-like
state. Nature 448, 318–324. doi: 10.
1038/nature05944
Won, K. J., Xu, Z., Zhang, X., Whitaker,
J. W., Shoemaker, R., Ren, B.,
et al. (2012). Global identi-
fication of transcriptional regula-
tors of pluripotency and differen-
tiation in embryonic stem cells.
Nucleic Acids Res. 40, 8199–8209.
doi: 10.1093/nar/gks584
Xu, C., Inokuma, M. S., Denham, J.,
Golds, K., Kundu, P., Gold, J. D.,
et al. (2001). Feeder-free growth
of undifferentiated human embry-
onic stem cells. Nat. Biotechnol. 19,
971–974. doi: 10.1038/nbt1001-971
Xu, H., Baroukh, C., Dannenfelser, R.,
Chen, E. Y., Tan, C. M., Kou, Y.,
et al. (2013). ESCAPE: database
for integrating high-content pub-
lished data collected from human
and mouse embryonic stem cells.
Database (Oxford) 2013:bat045. doi:
10.1093/database/bat045
Xu, R. H., Chen, X., Li, D. S., Li,
R., Addicks, G. C., Glennon, C., et
al. (2002). BMP4 initiates human
embryonic stem cell differentiation
to trophoblast. Nat. Biotechnol. 20,
1261–1264.
Xu, C., Rosler, E., Jiang, J., Lebkowski,
J. S., Gold, J. D., O’Sullivan, C.,
et al. (2005a). Basic fibroblast
growth factor supports undiffer-
entiated human embryonic stem
cell growth without conditioned
medium. Stem Cells 23, 315–323.
doi: 10.1038/nbt761
Xu, R. H., Peck, R. M., Li, D. S., Feng,
X., Ludwig, T., and Thomson, J. A.
(2005b). Basic FGF and suppression
of BMP signaling sustain undiffer-
entiated proliferation of human ES
cells. Nat. Methods 2, 185–190. doi:
10.1038/nmeth744
Xu, R. H., Sampsell-Barron, T. L., Gu,
F., Root, S., Peck, R. M., Pan, G.,
et al. (2008). NANOG is a direct
target of TGFbeta/activin-mediated
SMAD signaling in human ESCs.
Cell Stem Cell 3, 196–206. doi:
10.1016/j.stem.2008.07.001
Ying, Q. L., Wray, J., Nichols, J., Batlle-
Morera, L., Doble, B., Woodgett,
J., et al. (2008). The ground
state of embryonic stem cell self-
renewal. Nature 453, 519–523. doi:
10.1038/nature06968
Yu, J., Vodyanik, M. A., Smuga-Otto,
K., Antosiewicz-Bourget, J., Frane,
J. L., Tian, S., et al. (2007). Induced
pluripotent stem cell lines derived
from human somatic cells. Science
318, 1917–1920. doi: 10.1126/sci-
ence.1151526
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 23 July 2013; accepted: 02
October 2013; published online: 28
October 2013.
Citation: Peterson H, Abu Dawud R,
Garg A, Wang Y, Vilo J, Xenarios I
and Adjaye J (2013) Qualitative model-
ing identifies IL-11 as a novel regulator
in maintaining self-renewal in human
pluripotent stem cells. Front. Physiol.
4:303. doi: 10.3389/fphys.2013.00303
This article was submitted to Systems
Biology, a section of the journal Frontiers
in Physiology.
Copyright © 2013 Peterson, Abu
Dawud, Garg, Wang, Vilo, Xenarios and
Adjaye. This is an open-access article dis-
tributed under the terms of the Creative
Commons Attribution License (CC BY).
The use, distribution or reproduction
in other forums is permitted, provided
the original author(s) or licensor are
credited and that the original publication
in this journal is cited, in accordance
with accepted academic practice. No use,
distribution or reproduction is permit-
ted which does not comply with these
terms.
Research Topic: Topic Editor:
From  structural  to  molecular  systems  biology:  experimental  and Maeo Barberis,
computaonal approaches to unravel mechanisms of kinase acvity Humboldt University Berlin, Germany;
regulaon in cancer and neurodegeneraon Max Planck Instute for Molecular Genecs, Berlin, Germany
www.frontiersin.org October 2013 | Volume 4 | Article 303 | 13
